FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yan-Hua Wang

Research Profile

Disorders

Physiology

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Hanae Shimura; Yan-Hua Wang; Naoki Mori; Michiko Okada; Toshiko Motoji
Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype.
Norina Tanaka; Yan-Hua Wang; Masayuki Shiseki; Minoko Takanashi; Toshiko Motoji
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
Osamu Yamada; Kohji Ozaki; Thoru Furukawa; Mitsuyo Machida; Yan-Hua Wang; Toshiko Motoji; Tsuyoshi Mitsuishi; Masaharu Akiyama; Hisashi Yamada; Kiyotaka Kawauchi; Rumiko Matsuoka
Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yan-Hua Wang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hanae Shimura; Yan-Hua Wang; Naoki Mori; Michiko Okada; Toshiko Motoji
Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype.
Leukemia & lymphoma 2012;53(8):1599-609.
2011: Norina Tanaka; Yan-Hua Wang; Masayuki Shiseki; Minoko Takanashi; Toshiko Motoji
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
Leukemia research 2011;35(9):1219-25.
2011: Osamu Yamada; Kohji Ozaki; Thoru Furukawa; Mitsuyo Machida; Yan-Hua Wang; Toshiko Motoji; Tsuyoshi Mitsuishi; Masaharu Akiyama; Hisashi Yamada; Kiyotaka Kawauchi; Rumiko Matsuoka
Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1.
Cellular signalling 2011;23(7):1119-27.
2011: Naoki Mori; Kentaro Yoshinaga; Kaori Tomita; Mari Ohwashi; Toshiaki Kondoh; Hanae Shimura; Yan-Hua Wang; Masayuki Shiseki; Michiko Okada; Toshiko Motoji
Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
Leukemia research 2011;35(4):516-21.
2009: Yan-Hua Wang; Minoko Takanashi; Kazue Tsuji; Norina Tanaka; Masayuki Shiseki; Naoki Mori; Toshiko Motoji
Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
Leukemia research 2009;33(7):902-7.
2008: Kentaro Yoshinaga; Naoki Mori; Yan-Hua Wang; Kaori Tomita; Masayuki Shiseki; Toshiko Motoji
JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.
International journal of hematology 2008;88(1):82-7.
2007: Masayuki Shiseki; Yukiko Kitagawa; Yan-Hua Wang; Kentaro Yoshinaga; Toshiaki Kondo; Hanae Kuroiwa; Michiko Okada; Naoki Mori; Toshiko Motoji
Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
Leukemia & lymphoma 2007;48(11):2141-4.
2003: Mitsuko Kotaki; Toshiko Motoji; Minoko Takanashi; Yan-Hua Wang; Hideaki Mizoguchi
Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line.
Cancer letters 2003;199(1):61-8.
2002: Jun-ichi Okutsu; Tatsuhiko Tsunoda; Yasuyuki Kaneta; Toyomasa Katagiri; Osamu Kitahara; Hitoshi Zembutsu; Rempei Yanagawa; Shuichi Miyawaki; Kazutaka Kuriyama; Nobuyuki Kubota; Yukihiro Kimura; Kohmei Kubo; Fumiharu Yagasaki; Toshio Higa; Hirokuni Taguchi; Tadasu Tobita; Hideki Akiyama; Akihiro Takeshita; Yan-Hua Wang; Toshiko Motoji; Ryuzo Ohno; Yusuke Nakamura
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.
Molecular cancer therapeutics 2002;1(12):1035-42.